Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
My American Story
Roads, Travel and Traffic
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Jobs
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
My American Story
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Jobs
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Regeneron Pharmaceuticals
(NQ:
REGN
)
676.69
-2.25 (-0.33%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 17, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
648,401
Open
676.05
Bid (Size)
670.00 (240)
Ask (Size)
683.00 (40)
Prev. Close
678.94
Today's Range
672.31 - 691.13
52wk Range
541.00 - 821.11
Shares Outstanding
91,779,465
Dividend Yield
0.56%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Regeneron Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – REGN
July 18, 2026
From
DJS Law Group
Via
Business Wire
REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
July 17, 2026
From
The Schall Law Firm
Via
Business Wire
Performance
YTD
-12.8%
-12.8%
1 Month
+10.5%
+10.5%
3 Month
-9.7%
-9.7%
6 Month
-7.8%
-7.8%
1 Year
+24.0%
+24.0%
More News
Read More
REGENERON ALERT: Bragar Eagel & Squire, P.C. is Investigating Regeneron Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
July 17, 2026
From
Bragar Eagel & Squire
Via
GlobeNewswire
REGN (NASDAQ:REGN) Presents a Classic Value Opportunity with Strong Fundamentals
↗
June 12, 2026
Via
Chartmill
REGN DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Regeneron Investors of Securities Class Action Lawsuit Deadline on September 14, 2026
July 17, 2026
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
3 High-Yield Dividend Stocks to Buy and Hold
↗
July 17, 2026
Via
The Motley Fool
Topics
Intellectual Property
Investor Notice: Robbins LLP Informs Investors of the Regeneron Pharmaceuticals, Inc. Class Action Lawsuit
July 16, 2026
From
Robbins LLP
Via
Business Wire
1 Large-Cap Stock with Exciting Potential and 2 We Turn Down
July 14, 2026
Via
StockStory
Wall Street Thinks This Biotech Stock Can Soar 45%. Here's Why Analysts Are Right.
↗
July 02, 2026
Via
The Motley Fool
Wall Street Thinks This High-Flying Biotech Stock Can Soar Another 57%
↗
July 01, 2026
Via
The Motley Fool
Hormuz Goes Quiet, Software Wakes Up, and Burry Picks a Side
↗
June 29, 2026
Via
Chartmill
Will SpaceX Stock Double Anytime Soon? No -- but These 3 Stocks Could
↗
June 29, 2026
Via
The Motley Fool
This Little-Known Biotech Just Delivered a Bigger IPO Pop Than SpaceX -- and Regeneron Is Already Invested
↗
June 27, 2026
Via
The Motley Fool
Topics
Initial Public Offering
Regeneron to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast
June 25, 2026
From
Regeneron Pharmaceuticals, Inc.
Via
GlobeNewswire
2 Underrated Weight Loss Stocks to Buy and Hold
↗
June 23, 2026
Via
The Motley Fool
Cemdisiran Regulatory Submissions Accepted for Review by FDA and EMA for the Treatment of Generalized Myasthenia Gravis (gMG)
June 22, 2026
From
Regeneron Pharmaceuticals, Inc.
Via
GlobeNewswire
This Stock Is Up 58% This Year. Is It too Late to Buy?
↗
June 17, 2026
Via
The Motley Fool
3 Profitable Stocks We Think Twice About
June 17, 2026
Via
StockStory
REGN Investors Have Opportunity to Join Regeneron Pharmaceuticals, Inc. Fraud Investigation with the Schall Law Firm
June 10, 2026
From
The Schall Law Firm
Via
Business Wire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Regeneron Pharmaceuticals, Inc. - REGN
June 09, 2026
From
Pomerantz LLP
Via
GlobeNewswire
Top S&P500 movers in Monday's session
↗
June 08, 2026
Via
Chartmill
Regeneron to Highlight Progress Across Its Metabolic Disease, Ophthalmology and Rare Disease Pipelines at ADA and ENDO
June 04, 2026
From
Regeneron Pharmaceuticals, Inc.
Via
GlobeNewswire
Why Regeneron (REGN) Stock Is Trading Up Today
June 03, 2026
Via
StockStory
2 S&P 500 Stocks with Solid Fundamentals and 1 We Find Risky
June 03, 2026
Via
StockStory
Topics
Stocks
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Regeneron Pharmaceuticals, Inc. - REGN
June 02, 2026
From
Pomerantz LLP
Via
GlobeNewswire
Frequently Asked Questions
Is Regeneron Pharmaceuticals publicly traded?
Yes, Regeneron Pharmaceuticals is publicly traded.
What exchange does Regeneron Pharmaceuticals trade on?
Regeneron Pharmaceuticals trades on the Nasdaq Stock Market
What is the ticker symbol for Regeneron Pharmaceuticals?
The ticker symbol for Regeneron Pharmaceuticals is REGN on the Nasdaq Stock Market
What is the current price of Regeneron Pharmaceuticals?
The current price of Regeneron Pharmaceuticals is 676.69
When was Regeneron Pharmaceuticals last traded?
The last trade of Regeneron Pharmaceuticals was at 07/17/26 04:00 PM ET
What is the market capitalization of Regeneron Pharmaceuticals?
The market capitalization of Regeneron Pharmaceuticals is 62.11B
How many shares of Regeneron Pharmaceuticals are outstanding?
Regeneron Pharmaceuticals has 62B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at
/week.
Subscribe Today